A Complete Guide to Constipation Market-Pipeline Review, H1 2016

Summary

 

Global Markets Direct’s, ‘Constipation – Pipeline Review, H1 2016, provides an overview of the Constipation pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Constipation, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Constipation and features dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Request a sample of this report @ http://www.orbisresearch.com/contacts/request-sample/143794

Scope

– The report provides a snapshot of the global therapeutic landscape of Constipation

– The report reviews pipeline therapeutics for Constipation by companies and universities/research institutes based on information derived from company and industry-specific sources

– The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

– The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

– The report reviews key players involved Constipation therapeutics and enlists all their major and minor projects

– The report assesses Constipation therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

– The report summarizes all the dormant and discontinued pipeline projects

– The report reviews latest news related to pipeline therapeutics for Constipation

Purchase a copy of Constipation-Pipeline Review, H1 2016 visit @ http://www.orbisresearch.com/contact/purchase/143794

Reasons to buy

– Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

– Identify and understand important and diverse types of therapeutics under development for Constipation

– Identify potential new clients or partners in the target demographic

– Develop strategic initiatives by understanding the focus areas of leading companies

– Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics

– Devise corrective measures for pipeline projects by understanding Constipation pipeline depth and focus of Indication therapeutics

– Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

– Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Companies Mentioned:

Aerpio Therapeutics, Inc.

Ajinomoto Pharmaceuticals Co., Ltd.

Akebia Therapeutics, Inc.

Amorepacific Corporation

Bayer AG

Bristol-Myers Squibb Company

Dr. Falk Pharma GmbH

Galapagos NV

Immuron Limited

Innate Pharma S.A.

Peptinov SAS

Pfizer Inc.

Prokarium Limited

Protalix BioTherapeutics, Inc.

RDD Pharma Ltd.

Saniona AB

Synovo GmbH

 

Some Points From TOC:

Table of Contents

Table of Contents 2

List of Tables 6

List of Figures 7

Introduction 8

Global Markets Direct Report Coverage 8

Constipation Overview 9

Therapeutics Development 10

Pipeline Products for Constipation – Overview 10

Pipeline Products for Constipation – Comparative Analysis 11

Constipation – Therapeutics under Development by Companies 12

Constipation – Therapeutics under Investigation by Universities/Institutes 14

Constipation – Pipeline Products Glance 15

Late Stage Products 15

Clinical Stage Products 16

Early Stage Products 17

Constipation – Products under Development by Companies 18

Constipation – Products under Investigation by Universities/Institutes 20

Leave a Reply

Designed by CyFocus.com
Powered by CyFocus.net